Show simple item record

dc.creatorEpps, Sharon V. R.
dc.creatorHarvey, Roger B.
dc.creatorByrd, J. Allen
dc.creatorPetrujkić, Branko
dc.creatorSedej, Ivana
dc.creatorBeier, Ross C.
dc.creatorPhillips, Timothy D.
dc.creatorHume, Michael E.
dc.creatorAnderson, Robin C.
dc.creatorNisbet, David J.
dc.date.accessioned2020-06-03T13:57:07Z
dc.date.available2020-06-03T13:57:07Z
dc.date.issued2015
dc.identifier.issn0360-1234
dc.identifier.urihttp://vet-erinar.vet.bg.ac.rs/handle/123456789/1226
dc.description.abstractCampylobacter jejuni is an important human food-borne pathogen that can contaminate meat and poultry during processing. Consequently, strategies are sought to reduce the carriage of C. jejuni in food animals before they arrive at the abattoir. Thymol is a natural product that reduces survivability of Campylobacter in vitro, but its rapid absorption from the proximal alimentary tract limits its bactericidal efficacy in vivo. Thymol-beta-d-glucopyranoside is more resistant to absorption than free thymol, but its administration to chickens has not been reported. In the present studies, 1mM thymol-beta-d-glucopyranoside was shown to exhibit near equal anti-Campylobacter activity as 1mM thymol when incubated anaerobically in avian crop or cecal contents in vitro, resulting in reductions of 1.10-2.32 log(10) colony forming units mL(-1) in C. jejuni concentrations after 24h incubation. In a follow-up live animal study, oral administration of thymol-beta-d-glucopyranoside, but not free thymol, significantly lowered (>10-fold) recovery of Campylobacter from the crop of market-aged broilers when compared to placebo-treated controls (n = 6 broilers/treatment). Neither thymol-beta-d-glucopyranoside nor thymol affected recovery of Campylobacter from cecal contents of the treated broilers. These results indicate that rapid absorption or passage of free thymol from the crop precluded its anti-Campylobacter activity at this site and throughout the entire gastrointestinal tract. Conversely, lower recovery of Campylobacter from the crop of birds treated with thymol-beta-d-glucopyranoside indicates this conjugate was retained and able to be hydrolyzed to biologically active free thymol at this site as intended, yet was not sufficiently protected to allow passage of efficacious amounts of the intact glycoside to the lower gut. Nevertheless, these results warrant further research to see if higher doses or encapsulation of thymol-beta-d-glucopyranoside or similar glycosides may yield an efficacious additive to reduce carriage of Campylobacter as well as other pathogens throughout the avian gut.en
dc.publisherTaylor & Francis Inc, Philadelphia
dc.rightsrestrictedAccess
dc.sourceJournal of Environmental Science and Health - Part B Pesticides, Food Contaminants, and Agricultural
dc.subjectfood-borne pathogenen
dc.subjectthymol-beta-d-glucopyranosideen
dc.subjectpoultryen
dc.subjectCampylobacter jejunien
dc.subjectAntimicrobialen
dc.subjectbeta-glycosidaseen
dc.subjectbroiler chickenen
dc.subjectfeed additiveen
dc.subjectavianen
dc.subjectthymolen
dc.titleComparative effect of thymol or its glucose conjugate, thymol-beta-d-glucopyranoside, on Campylobacter in avian gut contentsen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractЕппс, Схарон В. Р.; Седеј, Ивана; Беиер, Росс Ц.; Пхиллипс, Тимотхy Д.; Aндерсон, Робин Ц.; Нисбет, Давид Ј.; Бyрд, Ј. Aллен; Хуме, Мицхаел Е.; Петрујкић, Бранко; Харвеy, Рогер Б.;
dc.citation.volume50
dc.citation.issue1
dc.citation.spage55
dc.citation.epage61
dc.citation.other50(1): 55-61
dc.citation.rankM23
dc.identifier.wos000345228100007
dc.identifier.doi10.1080/03601234.2015.965634
dc.identifier.pmid25421628
dc.identifier.scopus2-s2.0-84911931721
dc.identifier.rcubconv_2028
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record